These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19297125)

  • 1. [Diagnosing the cause of acute dyspnea in elderly patients: role of biomarkers in emergencies].
    Teixeira A; Legrain S; Ray P
    Presse Med; 2009 Oct; 38(10):1506-15. PubMed ID: 19297125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
    Heining L; Giesa C; Ewig S
    Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide: a new measurement to distinguish cardiac from pulmonary causes of acute dyspnea.
    Conklin B
    J Emerg Nurs; 2005 Feb; 31(1):73-5; quiz 119-20. PubMed ID: 15682131
    [No Abstract]   [Full Text] [Related]  

  • 4. Common lung conditions: acute dyspnea.
    Delzell JE
    FP Essent; 2013 Jun; 409():17-22. PubMed ID: 23767418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
    Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
    Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of biomarkers in patients with dyspnea.
    Gori CS; Magrini L; Travaglino F; Di Somma S
    Eur Rev Med Pharmacol Sci; 2011 Feb; 15(2):229-40. PubMed ID: 21434492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
    Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
    Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea.
    Mueller C; Laule-Kilian K; Frana B; Rodriguez D; Rudez J; Scholer A; Buser P; Pfisterer M; Perruchoud AP
    J Intern Med; 2005 Jul; 258(1):77-85. PubMed ID: 15953135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of bedside tissue Doppler echocardiography and B-type natriuretic peptide (BNP) in differentiating congestive heart failure from noncardiac cause of acute dyspnea in elderly patients with a normal left ventricular ejection fraction and permanent, nonvalvular atrial fibrillation: insights from a prospective, monocenter study.
    Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Luccioni R; Ambrosi P
    Echocardiography; 2007 May; 24(5):499-507. PubMed ID: 17456069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
    Maisel AS; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Clopton P; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA;
    N Engl J Med; 2002 Jul; 347(3):161-7. PubMed ID: 12124404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease.
    Mueller C; Laule-Kilian K; Frana B; Rodriguez D; Scholer A; Schindler C; Perruchoud AP
    Am Heart J; 2006 Feb; 151(2):471-7. PubMed ID: 16442916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department.
    Chung T; Sindone A; Foo F; Dwyer A; Paoloni R; Janu MR; Wong H; Hall J; Freedman SB
    Am Heart J; 2006 Nov; 152(5):949-55. PubMed ID: 17070166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
    Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
    Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine.
    Wettersten N; Maisel AS
    Am J Med; 2016 Jun; 129(6):560-7. PubMed ID: 26844635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of cardiopulmonary ultrasound performed by the emergency physician in the management of acute dyspnea.
    Gallard E; Redonnet JP; Bourcier JE; Deshaies D; Largeteau N; Amalric JM; Chedaddi F; Bourgeois JM; Garnier D; Geeraerts T
    Am J Emerg Med; 2015 Mar; 33(3):352-8. PubMed ID: 25572643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [B-type natriuretic peptide--current use in the diagnosis and management of heart failure].
    Müller C; Kuster G; Büttner HJ; Buser P
    Herz; 2003 Aug; 28(5):374-9. PubMed ID: 12928736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of inferior vena cava diameter in the differential diagnosis of dyspneic patients; best sonographic measurement method?
    Yamanoğlu A; Çelebi Yamanoğlu NG; Parlak İ; Pınar P; Tosun A; Erkuran B; Akgür A; Satılmış Siliv N
    Am J Emerg Med; 2015 Mar; 33(3):396-401. PubMed ID: 25612468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
    Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
    QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea.
    Cabanes L; Richaud-Thiriez B; Fulla Y; Heloire F; Vuillemard C; Weber S; Dusser D
    Chest; 2001 Dec; 120(6):2047-50. PubMed ID: 11742939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.